212 related articles for article (PubMed ID: 37121101)
1. Prediction of microvascular invasion in combined hepatocellular-cholangiocarcinoma based on preoperative contrast-enhanced CT and clinical data.
Zhang J; Dong W; Li Y; Fu J; Jia N
Eur J Radiol; 2023 Jun; 163():110839. PubMed ID: 37121101
[TBL] [Abstract][Full Text] [Related]
2. Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance?
Wang X; Wang W; Ma X; Lu X; Li S; Zeng M; Xu K; Yang C
Eur Radiol; 2020 Oct; 30(10):5337-5347. PubMed ID: 32385649
[TBL] [Abstract][Full Text] [Related]
3. Preoperative evaluation of MRI features and inflammatory biomarkers in predicting microvascular invasion of combined hepatocellular cholangiocarcinoma.
Zhang J; Dong W; Liu W; Fu J; Liao T; Li Y; Huo L; Jia N
Abdom Radiol (NY); 2024 Mar; 49(3):710-721. PubMed ID: 38112787
[TBL] [Abstract][Full Text] [Related]
4. Prediction of Microvascular Invasion in Combined Hepatocellular-Cholangiocarcinoma Based on Pre-operative Clinical Data and Contrast-Enhanced Ultrasound Characteristics.
Chen Y; Lu Q; Zhu Y; Huang B; Dong Y; Wang W
Ultrasound Med Biol; 2022 Jul; 48(7):1190-1201. PubMed ID: 35397928
[TBL] [Abstract][Full Text] [Related]
5. Nomogram based on clinical and preoperative CT features for predicting the early recurrence of combined hepatocellular-cholangiocarcinoma: a multicenter study.
Zheng C; Gu XT; Huang XL; Wei YC; Chen L; Luo NB; Lin HS; Jin-Yuan L
Radiol Med; 2023 Dec; 128(12):1460-1471. PubMed ID: 37747668
[TBL] [Abstract][Full Text] [Related]
6. Radiological features and outcomes of combined hepatocellular-cholangiocarcinoma in patients undergoing surgical resection.
Chi CT; Chau GY; Lee RC; Chen YY; Lei HJ; Hou MC; Chao Y; Huang YH
J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):125-133. PubMed ID: 30876788
[TBL] [Abstract][Full Text] [Related]
7. Combining Preoperative Clinical and Imaging Characteristics to Predict MVI in Hepatitis B Virus-Related Combined Hepatocellular Carcinoma and Cholangiocarcinoma.
Huang SS; Zuo MX; Xie CM
J Pers Med; 2023 Jan; 13(2):. PubMed ID: 36836479
[TBL] [Abstract][Full Text] [Related]
8. Clinical and DCE-CT signs in predicting microvascular invasion in cHCC-ICC.
Liao ZJ; Lu L; Liu YP; Qin GG; Fan CG; Liu YP; Jia NY; Zhang L
Cancer Imaging; 2023 Nov; 23(1):112. PubMed ID: 37978567
[TBL] [Abstract][Full Text] [Related]
9. Nomogram based on preoperative clinical and MRI features to estimate the microvascular invasion status and the prognosis of solitary intrahepatic mass-forming cholangiocarcinoma.
Chen S; Wan L; Zhao R; Peng W; Liu X; Li L; Zhang H
Abdom Radiol (NY); 2024 Feb; 49(2):425-436. PubMed ID: 37889266
[TBL] [Abstract][Full Text] [Related]
10. Combined hepatocellular carcinoma-cholangiocarcinoma with a predominant HCC component: better survival and MRI-based prediction.
Xiao Y; Zheng X; Zhou C; Huang P; Wu F; Yang C; Zeng M
Eur Radiol; 2023 Feb; 33(2):1412-1421. PubMed ID: 36112193
[TBL] [Abstract][Full Text] [Related]
11. Integrated nomograms to predict overall survival and recurrence-free survival in patients with combined hepatocellular cholangiocarcinoma (cHCC) after liver resection.
Wang T; Yang X; Tang H; Kong J; Shen S; Qiu H; Wang W
Aging (Albany NY); 2020 Aug; 12(15):15334-15358. PubMed ID: 32788423
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors of microvascular invasion in patients with intrahepatic mass-forming cholangiocarcinoma based on magnetic resonance images.
Chen S; Wan L; Zhao R; Peng W; Li Z; Zou S; Zhang H
Abdom Radiol (NY); 2023 Apr; 48(4):1306-1319. PubMed ID: 36872324
[TBL] [Abstract][Full Text] [Related]
13. Major and ancillary features according to LI-RADS in the assessment of combined hepatocellular-cholangiocarcinoma.
Granata V; Fusco R; Venanzio Setola S; Sandomenico F; Luisa Barretta M; Belli A; Palaia R; Tatangelo F; Grassi R; Izzo F; Petrillo A
Radiol Oncol; 2020 May; 54(2):149-158. PubMed ID: 32463393
[TBL] [Abstract][Full Text] [Related]
14. Mass-forming intrahepatic cholangiocarcinoma: Can diffusion-weighted imaging predict microvascular invasion?
Zhou Y; Wang X; Xu C; Zhou G; Liu X; Gao S; Xu P
J Magn Reson Imaging; 2019 Jul; 50(1):315-324. PubMed ID: 30444023
[TBL] [Abstract][Full Text] [Related]
15. Risk stratification of LI-RADS M and LI-RADS 4/5 combined hepatocellular cholangiocarcinoma: prognostic values of MR imaging features and clinicopathological factors.
Wang Y; Zhu GQ; Zhou CW; Li N; Yang C; Zeng MS
Eur Radiol; 2022 Aug; 32(8):5166-5178. PubMed ID: 35316365
[TBL] [Abstract][Full Text] [Related]
16. Combined hepatocellular carcinoma-cholangiocarcinoma: MRI features correlated with tumor biomarkers and prognosis.
Zhou C; Wang Y; Ma L; Qian X; Yang C; Zeng M
Eur Radiol; 2022 Jan; 32(1):78-88. PubMed ID: 34279688
[TBL] [Abstract][Full Text] [Related]
17. Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma.
Lee S; Kim SH; Lee JE; Sinn DH; Park CK
J Hepatol; 2017 Sep; 67(3):526-534. PubMed ID: 28483680
[TBL] [Abstract][Full Text] [Related]
18. A machine-learning model based on dynamic contrast-enhanced MRI for preoperative differentiation between hepatocellular carcinoma and combined hepatocellular-cholangiocarcinoma.
Deng X; Liao Z
Clin Radiol; 2024 Jun; 79(6):e817-e825. PubMed ID: 38413354
[TBL] [Abstract][Full Text] [Related]
19. MRI-based radiomics signature: a potential imaging biomarker for prediction of microvascular invasion in combined hepatocellular-cholangiocarcinoma.
Zhou G; Zhou Y; Xu X; Zhang J; Xu C; Xu P; Zhu F
Abdom Radiol (NY); 2024 Jan; 49(1):49-59. PubMed ID: 37831165
[TBL] [Abstract][Full Text] [Related]
20. Combining imaging and tumour biopsy improves the diagnosis of combined hepatocellular-cholangiocarcinoma.
Gigante E; Ronot M; Bertin C; Ciolina M; Bouattour M; Dondero F; Cauchy F; Soubrane O; Vilgrain V; Paradis V
Liver Int; 2019 Dec; 39(12):2386-2396. PubMed ID: 31544304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
